相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot study
Benoit Pilmis et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Colonization resistance: metabolic warfare as a strategy against pathogenic Enterobacteriaceae
Nicolas G. Shealy et al.
CURRENT OPINION IN MICROBIOLOGY (2021)
Unearthing Antibiotic Resistance Associated with Disturbance-Induced Permafrost Thaw in Interior Alaska
Tracie J. Haan et al.
MICROORGANISMS (2021)
Effects of sepsis and its treatment measures on intestinal flora structure in critical care patients
Xiao-Juan Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Impact of non-antibiotic drugs on the human intestinal microbiome
Quentin Le Bastard et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2021)
Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review
Vitoria S. Foletto et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut model
H. C. Harris et al.
JOURNAL OF HOSPITAL INFECTION (2021)
Gut microbiome heritability is nearly universal but environmentally contingent
Laura Grieneisen et al.
SCIENCE (2021)
Effect of Diet and Dietary Components on the Composition of the Gut Microbiota
Ashley Beam et al.
NUTRIENTS (2021)
Effects of Antibiotic Treatment with Piperacillin/Tazobactam versus Ceftriaxone on the Composition of the Murine Gut Microbiota
Carola Venturini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Impact of narrow-spectrum penicillin V on the oral and faecal resistome in a young child treated for otitis media
Kjersti Sturod et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Impact of oral amoxicillin and amoxicillin/clavulanic acid treatment on bacterial diversity and β-lactam resistance in the canine faecal microbiota
Carmen Espinosa-Gongora et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Impact of Antibiotic-Resistant Bacteria on Immune Activation and Clostridioides difficile Infection in the Mouse Intestine
James W. Keith et al.
INFECTION AND IMMUNITY (2020)
Antibiotic Degradation by Commensal Microbes Shields Pathogens
Mergim Gjonbalaj et al.
INFECTION AND IMMUNITY (2020)
Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review
Benoit Pilmis et al.
MICROORGANISMS (2020)
Antimicrobial De-Escalation in the ICU: From Recommendations to Level of Evidence
Ines Lakbar et al.
ADVANCES IN THERAPY (2020)
Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance
Rene Niehus et al.
ELIFE (2020)
Effects of Antibiotics on the Intestinal Microbiota of Mice
Frederik Boetius Hertz et al.
ANTIBIOTICS-BASEL (2020)
Relationship between the composition of the intestinal microbiota and the tracheal and intestinal colonization by opportunistic pathogens in intensive care patients
Candice Fontaine et al.
PLOS ONE (2020)
Long-term effects of antimicrobial drugs on the composition of the human gut microbiota
M. Mulder et al.
GUT MICROBES (2020)
Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens
Charles Burdet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease
Sung-Eun Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution
T. Doan et al.
NATURE MEDICINE (2019)
The intestinal microbiota predisposes to traveler's diarrhea and to the carriage of multidrug-resistant Enterobacteriaceae after traveling to tropical regions
Stefano Leo et al.
GUT MICROBES (2019)
Impact of antibiotics on the intestinal microbiota needs to be re-defined to optimize antibiotic usage
E. Ruppe et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience
C. Legeay et al.
JOURNAL OF HOSPITAL INFECTION (2018)
Carbapenems and alternative beta-lactams for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: What impact on intestinal colonisation resistance?
Paul-Louis Woerther et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Extensive impact of non-antibiotic drugs on human gut bacteria
Lisa Maier et al.
NATURE (2018)
Characterization of a Novel blaKLUC Variant With Reduced β-Lactam Resistance From an IncA/C Group Plasmid in a Clinical Klebsiella pneumoniae Isolate
Pingping Li et al.
FRONTIERS IN MICROBIOLOGY (2018)
Short- and long-term effects of oral vancomycin on the human intestinal microbiota
Sandrine Isaac et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
Sohn Kim et al.
IMMUNOLOGICAL REVIEWS (2017)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
INTENSIVE CARE MEDICINE (2017)
Piperacillin-tazobactam as alternative to carbapenems for ICU patients
Benoit Pilmis et al.
ANNALS OF INTENSIVE CARE (2017)
Carriage of Enterobacteria Producing Extended-Spectrum beta-Lactamases and Composition of the Gut Microbiota in an Amerindian Community
Maria Jose Gosalbes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit
Alexis Tabah et al.
CLINICAL INFECTIOUS DISEASES (2016)
Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms
Rafael Araos et al.
CLINICAL INFECTIOUS DISEASES (2016)
Impact of a short exposure to levofloxacin on faecal densities and relative abundance of total and quinolone-resistant Enterobacteriaceae
J. Bernard et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition
E. Weiss et al.
INTENSIVE CARE MEDICINE (2016)
A diverse intrinsic antibiotic resistome from a cave bacterium
Andrew C. Pawlowski et al.
NATURE COMMUNICATIONS (2016)
Description and validation of a spectrum score method to measure antimicrobial de-escalation in healthcare associated pneumonia from electronic medical records data
Karl Madaras-Kelly et al.
BMC INFECTIOUS DISEASES (2015)
High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics
Etienne Ruppe et al.
CLINICAL INFECTIOUS DISEASES (2015)
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams
E. Weiss et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric)
Cedric Bretonniere et al.
INTENSIVE CARE MEDICINE (2015)
Gut microbiota and aging
Paul W. O'Toole et al.
SCIENCE (2015)
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study
Yang Jiao et al.
PATHOGENS AND GLOBAL HEALTH (2015)
Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore
Moi Lin Ling et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2015)
Gut Microbiome of an 11th Century AD Pre-Columbian Andean Mummy
Tasha M. Santiago-Rodriguez et al.
PLOS ONE (2015)
Global biogeography of Streptomyces antibiotic inhibition, resistance, and resource use
Daniel C. Schlatter et al.
FEMS MICROBIOLOGY ECOLOGY (2014)
De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock
J. Garnacho-Montero et al.
INTENSIVE CARE MEDICINE (2014)
Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime
P. Grohs et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Bacillary dysentery from World War 1 and NCTC1, the first bacterial isolate in the National Collection
Alison E. Mather et al.
LANCET (2014)
Pathogens and host immunity in the ancient human oral cavity
Christina Warinner et al.
NATURE GENETICS (2014)
Trends in Human Fecal Carriage of Extended-Spectrum β-Lactamases in the Community: Toward the Globalization of CTX-M
Paul-Louis Woerther et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
The Long-Term Stability of the Human Gut Microbiota
Jeremiah J. Faith et al.
SCIENCE (2013)
Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients
Leslie Gonzalez et al.
CRITICAL CARE (2013)
Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
Trevor D. Lawley et al.
PLOS PATHOGENS (2012)
Clinical Pharmacokinetics of Meropenem and Biapenem in Bile and Dosing Considerations for Biliary Tract Infections Based on Site-Specific Pharmacodynamic Target Attainment
Kazuro Ikawa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
De-Escalation Therapy: Is It Valuable for the Management of Ventilator-Associated Pneumonia?
Michael S. Niederman et al.
CLINICS IN CHEST MEDICINE (2011)
Co-resistance: an opportunity for the bacteria and resistance genes
Rafael Canton et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Antibiotic resistance is ancient
Vanessa M. D'Costa et al.
NATURE (2011)
Enterotypes of the human gut microbiome
Manimozhiyan Arumugam et al.
NATURE (2011)
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
Les Dethlefsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing
Les Dethlefsen et al.
PLOS BIOLOGY (2008)
Principles of antibiotic therapy in severe infections: Optimizing the therapeutic approach by use of laboratory and clinical data
Stan Deresinski
CLINICAL INFECTIOUS DISEASES (2007)
De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate
Elpis Giantsou et al.
INTENSIVE CARE MEDICINE (2007)
Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae strains in mice
Michael J. Pultz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
EFfect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice
Usha Stiefel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Spatial organization of bacterial flora in normal and inflamed intestine: A fluorescence in situ hybridization study in mice
Alexander Swidsinski et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man
BK Wong et al.
XENOBIOTICA (2004)
Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units:: Role of antibiotics with antipseudomonal activity
E Paramythiotou et al.
CLINICAL INFECTIOUS DISEASES (2004)
β-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types
C Humeniuk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
De-escalation Antimicrobial Chemotherapy in Critically Ill Patients: Pros and Cons
M. Antonelli et al.
JOURNAL OF CHEMOTHERAPY (2001)
分享论文
